🔗 Share this article

An underground economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Drug Acquiring Popularity Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are urged to message these profiles privately for supplier links, while also receiving discount codes.

Active Commerce on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with numerous of members share comparison photos, administration instructions and claims of next-day UK delivery. Vendors market the drug there before redirecting buyers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Express Concerns

However, doctors and pharmacists have cautions that the sale of what remains an unapproved medication in the UK is a cause for concern and could result in individuals administering substances of uncertain source.

Some experts said the popularity for the experimental drug could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate pharmaceutical, advertising, and consumer laws, risking fines, prosecution or prison.

Platform Response and Content Elimination

According to TikTok, the platform has removed violative content and banned related keywords and query recommendations. The company stated it was committed to maintaining the service secure and investing in enhancing compliance measures.

Online Trading Activities

Investigations also discovered communities with up to nine thousand participants selling retatrutide using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays groups with numerous of members, filled with photos of weight loss, positive reviews and step-by-step instructions for preparing or injecting at residence.

After moments of entering one community, a seller shared contact information, where most transactions take place. The vendor sent an instruction manual and promised shipping within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about weight, medical conditions or previous experience.

Product Information and Costs

Inside these groups, posts show black plastic parcels with postal service labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with purified liquid, or pre-filled injectors typically sold at 160 pounds for 20mg. When questioned how much time a pen should last, vendors give contradictory responses ranging from a several days to “depends on your body”.

Platform Oversight and Safety Actions

A representative for the messaging service said it regularly monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering materials they cannot confirm. Even if the science behind this drug is valid, these online products may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to current price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.

Her staff has previously encountered patients harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may expose users to potentially significant health risks”.